Springstubb Brendan B 4
4 · Evolent Health, Inc. · Filed Nov 19, 2025
Insider Transaction Report
Form 4
Springstubb Brendan B
Director
Transactions
- Purchase
Class A Common Stock
2025-11-18$3.82/sh+10,000$38,199→ 58,821 total
Footnotes (1)
- [F1]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.